Integrated Diagnostics (IDHC) Competitors GBX 0.43 +0.00 (+0.47%) (As of 06:11 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitors IDHC vs. PRM, GENI, VRCI, LLAI, DMTR, LLA, DXRX, AGL, YGEN, and ABDXShould you be buying Integrated Diagnostics stock or one of its competitors? The main competitors of Integrated Diagnostics include Proteome Sciences (PRM), GENinCode (GENI), Verici Dx (VRCI), LungLife AI (LLAI), Deepmatter Group (DMTR), LLA.L,0P0001T9GN,0 (LLA), Diaceutics (DXRX), ANGLE (AGL), Yourgene Health (YGEN), and Abingdon Health (ABDX). These companies are all part of the "diagnostics & research" industry. Integrated Diagnostics vs. Proteome Sciences GENinCode Verici Dx LungLife AI Deepmatter Group LLA.L,0P0001T9GN,0 Diaceutics ANGLE Yourgene Health Abingdon Health Proteome Sciences (LON:PRM) and Integrated Diagnostics (LON:IDHC) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, media sentiment, earnings, institutional ownership, community ranking, valuation, dividends and profitability. Does the MarketBeat Community prefer PRM or IDHC? Proteome Sciences received 106 more outperform votes than Integrated Diagnostics when rated by MarketBeat users. However, 65.12% of users gave Integrated Diagnostics an outperform vote while only 57.04% of users gave Proteome Sciences an outperform vote. CompanyUnderperformOutperformProteome SciencesOutperform Votes16257.04% Underperform Votes12242.96% Integrated DiagnosticsOutperform Votes5665.12% Underperform Votes3034.88% Which has more volatility & risk, PRM or IDHC? Proteome Sciences has a beta of 0.07, indicating that its stock price is 93% less volatile than the S&P 500. Comparatively, Integrated Diagnostics has a beta of 0.59, indicating that its stock price is 41% less volatile than the S&P 500. Is PRM or IDHC more profitable? Integrated Diagnostics has a net margin of 17.21% compared to Proteome Sciences' net margin of -101.07%. Integrated Diagnostics' return on equity of 23.03% beat Proteome Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Proteome Sciences-101.07% N/A -19.25% Integrated Diagnostics 17.21%23.03%9.69% Which has stronger earnings & valuation, PRM or IDHC? Integrated Diagnostics has higher revenue and earnings than Proteome Sciences. Proteome Sciences is trading at a lower price-to-earnings ratio than Integrated Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProteome Sciences£4.04M1.76-£4.08M-£0.01-240.30Integrated Diagnostics£4.75B0.00£817.28M£0.0314.40 Do insiders and institutionals believe in PRM or IDHC? 23.0% of Proteome Sciences shares are held by institutional investors. Comparatively, 43.0% of Integrated Diagnostics shares are held by institutional investors. 19.5% of Proteome Sciences shares are held by company insiders. Comparatively, 34.0% of Integrated Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the media refer more to PRM or IDHC? In the previous week, Proteome Sciences' average media sentiment score of 0.00 equaled Integrated Diagnostics'average media sentiment score. Company Overall Sentiment Proteome Sciences Neutral Integrated Diagnostics Neutral SummaryIntegrated Diagnostics beats Proteome Sciences on 11 of the 13 factors compared between the two stocks. Ad DTIWhy I'm telling friends to avoid gold stocksBack in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown. Get Integrated Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for IDHC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart IDHC vs. The Competition Export to ExcelMetricIntegrated DiagnosticsDiagnostics & Research IndustryMedical SectorLON ExchangeMarket Cap£2.51M£26.28M£4.98B£1.43BDividend Yield14.08%5.44%7.70%11.78%P/E Ratio14.401.9977.291,574.07Price / Sales0.001,657.431,377.39253,967.78Price / CashN/A17.8934.4033.08Price / Book0.002.354.822.90Net Income£817.28M£26.61M£114.44M£152.99M7 Day Performance4.73%-1.81%6.65%8.48%1 Month Performance-1.14%-1.63%122.41%16.49%1 Year Performance39.35%-0.83%157.30%18.71% Integrated Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IDHCIntegrated DiagnosticsN/AGBX 0.43+0.5%N/A+34.2%£2.51M£4.75B14.406,692PRMProteome SciencesN/AGBX 3.04+20.9%N/A-42.3%£8.97M£4.04M-304.00240Gap UpGENIGENinCodeN/AGBX 4.01-11.0%N/A-32.1%£7.09M£2.60M-80.102,300Gap DownVRCIVerici DxN/AGBX 2.85-5.0%N/A-64.0%£6.91M£4.33M-140.7519Gap UpHigh Trading VolumeLLAILungLife AIN/AGBX 9.25-4.9%N/A-88.1%£2.84M£98,566.00-71.1515Gap DownHigh Trading VolumeDMTRDeepmatter GroupN/AGBX 0.03+22.2%N/AN/A£1.33M£1.04M-0.11N/AGap DownLLALLA.L,0P0001T9GN,0N/AGBX 15flatN/AN/A£0.00N/A-125.0015High Trading VolumeDXRXDiaceutics1.9997 of 5 starsGBX 116-1.1%GBX 160+37.9%+26.4%£97.99M£26.09M-3,866.67151News CoverageAGLANGLE1.2273 of 5 starsGBX 9.66flatGBX 70+624.7%-1.1%£31.15M£2.02M-140.99650YGENYourgene HealthN/AN/AN/AN/A£16.43M£29.67M-51.50253ABDXAbingdon HealthN/AGBX 7.50+7.1%N/A-14.1%£14.21M£6.13M-899.0084Positive News Related Companies and Tools Related Companies PRM Alternatives GENI Alternatives VRCI Alternatives LLAI Alternatives DMTR Alternatives LLA Alternatives DXRX Alternatives AGL Alternatives YGEN Alternatives ABDX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:IDHC) was last updated on 12/9/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Integrated Diagnostics Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Integrated Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
